Effects of Sage on Memory and Mental Performance in Alzheimer's Disease Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00110552|
Recruitment Status : Completed
First Posted : May 11, 2005
Last Update Posted : October 29, 2014
The purpose of this study is to determine the effectiveness of the herb sage in improving the mental function of individuals with Alzheimer's disease.
Study hypothesis: The administration of sage will improve cognitive function in patients with mild Alzheimer's disease.
|Condition or disease||Intervention/treatment||Phase|
|Alzheimer Disease||Drug: Salvia officinalis (sage)||Phase 1|
The herb sage has been shown to enhance memory and mental function in healthy, young adults. However, studies assessing the herb's effectiveness in older adults with symptoms of Alzheimer's disease are limited. This study will determine the effect of sage extract on the cognitive function of patients with mild Alzheimer's disease.
This study will last 6 weeks and will comprise 4 study visits, approximately 10 days apart. Participants will be randomly assigned to receive either sage pills or no treatment during each 10-day period. The treatment assignments will be switched in 10-day intervals, so that during the course of the study, each participant will undergo two periods of sage treatment and two periods without treatment. At each study visit, participants will undergo cognitive testing, including tests to determine attention, memory, and visual cognition. Participants will also undergo an electroencephalogram (EEG) and an electrocardiogram (ECG) at each visit.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||111 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Effects of a Cognitive Enhancer on Memory and Cognitive Performance|
|Study Start Date :||July 2005|
|Actual Primary Completion Date :||December 2012|
|Actual Study Completion Date :||October 2014|
U.S. FDA Resources
Sage capsules taken by mouth
Drug: Salvia officinalis (sage)
Other Name: sage
No Intervention: 2
No intervention, no-pill as control
- Cognitive function [ Time Frame: 8 weeks ]
- Stress [ Time Frame: 8 weeks ]
- cognitive electrophysiology [ Time Frame: 8 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00110552
|United States, Oregon|
|Oregon Health and Science University|
|Portland, Oregon, United States, 97239|
|Principal Investigator:||Barry Oken, MD||Oregon Health and Science University|